JERSEY CITY, N.J., Feb. 13, 2025 /PRNewswire/ — Exero Medical, a US and Israel based company focused on early detection of post-operative complications using tissue healing data, has secured up to $12.7M in funding to complete its FDA pivotal trial and launch its breakthrough-designated…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.